Stem Cell Company TheraVitae Establishes Subsidiary In North America
7/12/2006 1:01:12 PM
07/12/2006 - TheraVitae, an international biotechnology company, the producer of VesCell(TM) a cellular therapy for heart disease and developer of additional adult stem cell technologies for incurable disorders completed a North American license agreement with TheraVitae Inc., which establishes TheraVitae Inc. as an exclusive licensee of North America. In parallel with the closing of the agreement, TheraVitae Inc. completed a $3,000,000 non-brokered private placement.
comments powered by